Figure 3.
Outcomes in children with acute lymphoblastic leukemia who received reduced-intensity therapy. (A) Relapse-free survival according to MRD levels on day 19; (B) cumulative incidence of relapse according to MRD levels on day 19.
Outcomes in children with acute lymphoblastic leukemia who received reduced-intensity therapy. (A) Relapse-free survival according to MRD levels on day 19; (B) cumulative incidence of relapse according to MRD levels on day 19.